KPRX
Kiora Pharmaceuticals Inc
NASDAQ: KPRX · HEALTHCARE · BIOTECHNOLOGY
$2.44
+3.83% today
Updated 2026-05-01
Market cap
$10.53M
P/E ratio
—
P/S ratio
0.14x
EPS (TTM)
$-2.64
Dividend yield
—
52W range
$2 – $4
Volume
0.6M
Kiora Pharmaceuticals Inc (KPRX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-51.70%
ROA
-19.50%
Debt/equity
0.02x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2012 | — | $-6.03M | — | — | — |
| 2013 | — | $-3.88M | — | — | — |
| 2014 | — | $-1.77M | — | — | — |
| 2015 | — | $-8.39M | — | — | — |
| 2016 | $669259.00 | $-13.34M | -1,158.49% | -1,994.27% | -1,993.76% |
| 2017 | $407518.00 | $-13.22M | -2,434.94% | -3,572.66% | -3,243.52% |
| 2018 | $1.65M | $-10.81M | -387.48% | -656.25% | -654.24% |
| 2019 | $2.69M | $-7.10M | 99.82% | -260.65% | -264.21% |
| 2020 | $12059.00 | $-6.86M | -27,038.66% | -56,960.51% | -56,901.65% |
| 2021 | $12059.00 | $-13.77M | -1,884.68% | -118,050.98% | -114,194.25% |
| 2022 | $0.00 | $-13.58M | — | — | — |
| 2023 | $0.00 | $-12.51M | — | — | — |
| 2024 | $16.00M | $3.59M | 100.00% | 28.19% | 22.47% |
| 2025 | $0.00 | $-10.84M | — | — | — |